All News about Fulcrum Therapeutics Inc
FDA Slams Break On Fulcrum Therapeutics' Sickle Cell Disease Study, Shares Plummet
February 24, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 24, 2023
Via Benzinga
Expert Ratings for Fulcrum Therapeutics
January 19, 2023
Via Benzinga
Looking Into Fulcrum Therapeutics's Return On Capital Employed
December 06, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 17, 2023
Via Benzinga
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 16, 2023
Via Benzinga
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
January 04, 2023
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|